{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:03:25Z","timestamp":1784311405607,"version":"3.55.0"},"reference-count":210,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>Swine Group A rotavirus is one of the primary intestinal pathogens causing severe diarrhea in newborn piglets, with high incidence and mortality resulting in substantial economic losses to the global swine industry. Vaccination, alongside rigorous biosecurity measures, remains the core strategy for controlling porcine Group A rotavirus infection; however, continuous genetic variation via genomic reassortment, point mutations, and diverse G\/P genotype combinations drives the constant emergence of new circulating strains that may evade immune protection from existing vaccines. These genetic changes may also give rise to highly pathogenic variants, increasing large-scale outbreak risk. Therefore, developing vaccines that provide stable, broad cross-protection against viral strain diversity is particularly critical. Vaccine adjuvants play a vital role in enhancing and modulating immune responses, broadening protection spectra, and reducing the antigen dose required for protection especially valuable when facing rapidly changing genotypes or limited vaccine antigen supplies. In recent years, advances in adjuvant design and formulation strategies have clearly improved the immunogenicity and duration of protection of swine Group A rotavirus vaccines, as evidenced by significantly reduced diarrhea incidence and viral shedding intensity in vaccinated piglets. Building on an overview of the current status, advantages, and challenges of different porcine Group A rotavirus vaccine types, this review focuses on the mechanisms of action, application advantages, existing limitations, and methodological strategies of adjuvants. It further analyzes the potential contribution of adjuvant strategies to developing a universal porcine rotavirus vaccine capable of broad, long-lasting cross-protection. Finally, this review identifies key unresolved scientific questions and critical knowledge gaps in the field, with the aim of guiding future research priorities.<\/jats:p>","DOI":"10.3389\/fvets.2026.1896748","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:22:16Z","timestamp":1784308936000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Swine Group A rotavirus vaccines: current status, adjuvant strategies, challenges, and future perspectives"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhang","family":"Zhen","sequence":"first","affiliation":[{"name":"College of Animal Science and Technology, Tarim University","place":["Alar, Xinjiang, China"]},{"name":"Tarim Animal Husbandry Science and Technology Key Laboratory of Xinjiang Production and Construction Corps","place":["Alar, Xinjiang, China"]},{"name":"Tarim Animal Disease Diagnosis and Prevention Engineering Laboratory of Xinjiang Production and Construction Corps","place":["Alar, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma","family":"Baihe","sequence":"additional","affiliation":[{"name":"College of Animal Science and Technology, Tarim University","place":["Alar, Xinjiang, China"]},{"name":"Tarim Animal Husbandry Science and Technology Key Laboratory of Xinjiang Production and Construction Corps","place":["Alar, Xinjiang, China"]},{"name":"Tarim Animal Disease Diagnosis and Prevention Engineering Laboratory of Xinjiang Production and Construction Corps","place":["Alar, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Hongmiao","sequence":"additional","affiliation":[{"name":"College of Animal Science and Technology, Tarim University","place":["Alar, Xinjiang, China"]},{"name":"Tarim Animal Husbandry Science and Technology Key Laboratory of Xinjiang Production and Construction Corps","place":["Alar, Xinjiang, China"]},{"name":"Tarim Animal Disease Diagnosis and Prevention Engineering Laboratory of Xinjiang Production and Construction Corps","place":["Alar, Xinjiang, China"]},{"name":"Bayinguoleng Vocational and Technical College","place":["Korla, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Meiliang","sequence":"additional","affiliation":[{"name":"College of Animal Science and Technology, Tarim University","place":["Alar, Xinjiang, China"]},{"name":"Tarim Animal Husbandry Science and Technology Key Laboratory of Xinjiang Production and Construction Corps","place":["Alar, Xinjiang, China"]},{"name":"Tarim Animal Disease Diagnosis and Prevention Engineering Laboratory of Xinjiang Production and Construction Corps","place":["Alar, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Shuhua","sequence":"additional","affiliation":[{"name":"College of Animal Science and Technology, Tarim University","place":["Alar, Xinjiang, China"]},{"name":"Tarim Animal Husbandry Science and Technology Key Laboratory of Xinjiang Production and Construction Corps","place":["Alar, Xinjiang, China"]},{"name":"Tarim Animal Disease Diagnosis and Prevention Engineering Laboratory of Xinjiang Production and Construction Corps","place":["Alar, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lianrui","sequence":"additional","affiliation":[{"name":"College of Animal Science and Technology, Tarim University","place":["Alar, Xinjiang, China"]},{"name":"Tarim Animal Husbandry Science and Technology Key Laboratory of Xinjiang Production and Construction Corps","place":["Alar, Xinjiang, China"]},{"name":"Tarim Animal Disease Diagnosis and Prevention Engineering Laboratory of Xinjiang Production and Construction Corps","place":["Alar, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/pathogens11101078","article-title":"Rotavirus infection in swine: genotypic diversity, immune responses, and role of gut microbiome in rotavirus immunity","volume":"11","author":"Kumar","year":"2022","journal-title":"Pathogens (Basel, Switzerland)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3390\/vetsci12121137","article-title":"Molecular epidemiological investigation and viral isolation of porcine rotavirus in Southwest China during 2024-2025","volume":"12","author":"He","year":"2025","journal-title":"Vet Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/v9030048","article-title":"Porcine rotaviruses: epidemiology, immune responses and control strategies","volume":"9","author":"Vlasova","year":"2017","journal-title":"Viruses"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"veag013","DOI":"10.1093\/ve\/veag013","article-title":"Genetic and antigenic diversity of rotavirus a in faeces from Danish pigs","volume":"12","author":"Pedersen","year":"2026","journal-title":"Virus Evol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1080\/14787210.2022.2139239","article-title":"Genetic heterogeneity of Group A rotaviruses: a review of the evolutionary dynamics and implication on vaccination","volume":"20","author":"Omatola","year":"2022","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"8213","DOI":"10.1128\/JVI.71.11.8213-8220.1997","article-title":"Single point mutations may affect the serotype reactivity of serotype G11 porcine rotavirus strains: a widening spectrum?","volume":"71","author":"Ciarlet","year":"1997","journal-title":"J Virol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/vetsci11090436","article-title":"Isolation, genomic characterization and evolution of six porcine rotavirus a strains in a pig farming group","volume":"11","author":"Zhang","year":"2024","journal-title":"Vet Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1111919","DOI":"10.3389\/fvets.2022.1111919","article-title":"Emergence of human-porcine reassortment G9P(19) porcine rotavirus a strain in Guangdong Province, China","volume":"9","author":"Luo","year":"2023","journal-title":"Front Vet Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/BF03548067","article-title":"Epidemiological studies of piglet diarrhoea in intensively managed Danish sow herds. I. Pre-weaning diarrhoea","volume":"30","author":"Svensmark","year":"1989","journal-title":"Acta Vet Scand"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13567-018-0619-6","article-title":"Development of a live attenuated trivalent porcine rotavirus a vaccine against disease caused by recent strains most prevalent in South Korea","volume":"50","author":"Park","year":"2019","journal-title":"Vet Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.3390\/v14112554","article-title":"Zoonotic RVA: state of the art and distribution in the animal world","volume":"14","author":"D\u00edaz Alarc\u00f3n","year":"2022","journal-title":"Viruses"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e0201525","DOI":"10.1128\/jvi.02015-25","article-title":"Simultaneous expression of three G genotypes of VP7 proteins in a recombinant porcine rotavirus confers protective immunity against multiple rotavirus infections","volume":"100","author":"Cheng","year":"2026","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.vetimm.2008.10.298","article-title":"Strategies to link innate and adaptive immunity when designing vaccine adjuvants","volume":"128","author":"Garlapati","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1016\/j.vaccine.2010.02.063","article-title":"Rotavirus enterotoxin NSP4 has mucosal adjuvant properties","volume":"28","author":"Kavanagh","year":"2010","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"110130","DOI":"10.1016\/j.virol.2024.110130","article-title":"The synergy of recombinant NSP4 and VP4 from porcine rotavirus elicited a strong mucosal response","volume":"597","author":"Li","year":"2024","journal-title":"Virology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"113784","DOI":"10.1016\/j.intimp.2024.113784","article-title":"Advancing novel veterinary vaccines: from comprehensive antigen and adjuvant design to preparation process optimization","volume":"145","author":"Zhang","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"31809","DOI":"10.1021\/acsnano.4c07061","article-title":"VP8 mosaic nanoparticles elicit Cross-neutralizing immune responses and provide protection against heterotypic rotavirus challenge in mice","volume":"18","author":"Song","year":"2024","journal-title":"ACS Nano"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.1016\/j.vaccine.2017.05.067","article-title":"A novel combination adjuvant platform for human and animal vaccines","volume":"35","author":"Garg","year":"2017","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1128\/JCM.03193-12","article-title":"Detection and genetic diversity of porcine Group A rotaviruses in historic (2004) and recent (2011 and 2012) swine fecal samples in Ohio: predominance of the G9P[13] genotype in nursing piglets","volume":"51","author":"Amimo","year":"2013","journal-title":"J Clin Microbiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.virusres.2011.07.015","article-title":"Phylogenetic analysis of VP1, VP2, and VP3 gene segments of genotype G5 Group A rotavirus strains circulating in Brazil between 1986 and 2005","volume":"160","author":"da Silva","year":"2011","journal-title":"Virus Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.meegid.2007.05.001","article-title":"Genetic heterogeneity, evolution and recombination in emerging G9 rotaviruses","volume":"7","author":"Phan","year":"2007","journal-title":"Infect Genet Evol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.vetmic.2013.03.020","article-title":"Review of Group A rotavirus strains reported in swine and cattle","volume":"165","author":"Papp","year":"2013","journal-title":"Vet Microbiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1128\/CDLI.8.1.129-132.2001","article-title":"Genomic characterization of porcine rotaviruses in Italy","volume":"8","author":"Martella","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1007\/s00018-016-2299-6","article-title":"Mechanisms of viral mutation","volume":"73","author":"Sanju\u00e1n","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e02680","DOI":"10.1016\/j.heliyon.2019.e02680","article-title":"Phylogeography and evolutionary analysis of African rotavirus a genotype G12 reveals district genetic diversification within lineage III","volume":"5","author":"Motayo","year":"2019","journal-title":"Heliyon"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/v12080831","article-title":"Genetic characterizations and molecular evolution of VP7 gene in human Group A rotavirus G1","volume":"12","author":"Zhou","year":"2020","journal-title":"Viruses"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.virs.2022.05.005","article-title":"Genotype distribution and evolutionary analysis of rotavirus associated with acute diarrhea outpatients in Hubei, China, 2013-2016","volume":"37","author":"Zhang","year":"2022","journal-title":"Virol Sin"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.vetmic.2011.06.026","article-title":"Genetic heterogeneity of wild-type G4P(6) porcine rotavirus strains detected in a diarrhea outbreak in a regularly vaccinated pig herd","volume":"154","author":"Lorenzetti","year":"2011","journal-title":"Vet Microbiol"},{"key":"ref29","volume-title":"WAHIS: World Animal Health Information System (Database)","year":"2025"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"110358","DOI":"10.1016\/j.vetmic.2024.110358","article-title":"A matched case-control study of porcine Group A and C rotaviruses in a swine farrowing production system","volume":"301","author":"Lachapelle","year":"2025","journal-title":"Vet Microbiol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1138419","DOI":"10.3389\/fvets.2023.1138419","article-title":"Molecular epidemiological investigation of Group A porcine rotavirus in East China","volume":"10","author":"Tao","year":"2023","journal-title":"Front Vet Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"4232389","DOI":"10.1155\/2024\/4232389","article-title":"Detection of porcine-human Reassortant and zoonotic Group A rotaviruses in humans in Poland","volume":"2024","author":"Kozyra","year":"2024","journal-title":"Transbound Emerg Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.meegid.2016.03.001","article-title":"Phylogenetic inference of the porcine rotavirus a origin of the human G1 VP7 gene","volume":"40","author":"Do","year":"2016","journal-title":"Infect Genet Evol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.virol.2005.03.031","article-title":"Sequence analysis of the VP7 and VP4 genes identifies a novel VP7 gene allele of porcine rotaviruses, sharing a common evolutionary origin with human G2 rotaviruses","volume":"337","author":"Martella","year":"2005","journal-title":"Virology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.vetmic.2007.06.006","article-title":"Phylogenetic analysis of porcine rotavirus in Argentina: increasing diversity of G4 strains and evidence of interspecies transmission","volume":"126","author":"Parra","year":"2008","journal-title":"Vet Microbiol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1111\/tbed.14712","article-title":"Full genome characterization of a human-porcine reassortment G12P[7] rotavirus and its pathogenicity in piglets","volume":"69","author":"Miao","year":"2022","journal-title":"Transbound Emerg Dis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1038\/s41598-019-38703-7","article-title":"First detection of DS-1-like G1P(8) double-gene reassortant rotavirus strains on the American continent, Brazil, 2013","volume":"9","author":"Luchs","year":"2019","journal-title":"Sci Rep"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1017\/S0950268816000807","article-title":"Unusual rotavirus genotypes in humans and animals with acute diarrhoea in Northeast India","volume":"144","author":"Chakraborty","year":"2016","journal-title":"Epidemiol Infect"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3390\/pathogens14121230","article-title":"Interspecies transmission of animal rotaviruses to humans: Reassortment-driven adaptation","volume":"14","author":"Nakagomi","year":"2025","journal-title":"Pathogens (Basel, Switzerland)"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12917-025-04776-y","article-title":"Prevalence and genetic diversity of porcine rotavirus a from diarrheic piglets in northern Thailand","volume":"21","author":"Jampanil","year":"2025","journal-title":"BMC Vet Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"105198","DOI":"10.1016\/j.meegid.2021.105198","article-title":"Prevalence and diversity of rotavirus a in pigs: evidence for a possible reservoir in human infection","volume":"98","author":"Wu","year":"2022","journal-title":"Infect Genet Evol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0165-2427(02)00046-6","article-title":"Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model","volume":"87","author":"Yuan","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ddmod.2019.08.006","article-title":"Interactions between human microbiome, diet, enteric viruses and immune system: novel insights from gnotobiotic pig research","volume":"28","author":"Vlasova","year":"2018","journal-title":"Drug Discov Today Dis Models"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1586\/erv.13.3","article-title":"Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease","volume":"12","author":"Azevedo","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/vaccines12030260","article-title":"mRNA-based vaccines are highly immunogenic and confer protection in the gnotobiotic pig model of human rotavirus diarrhea","volume":"12","author":"Hensley","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1385\/1-59259-078-0:147","article-title":"Evaluation of rotavirus vaccines in small animal models","volume":"34","author":"Ciarlet","year":"2000","journal-title":"Methods Mol Med"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e0055022","DOI":"10.1128\/jvi.00550-22","article-title":"The role of the VP4 attachment protein in rotavirus host range restriction in an in vivo suckling mouse model","volume":"96","author":"S\u00e1nchez-Tacuba","year":"2022","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1093\/infdis\/174.supplement_1.s98","article-title":"Group A rotavirus veterinary vaccines","volume":"174","author":"Saif","year":"1996","journal-title":"J Infect Dis"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/BF00237102","article-title":"A comparison of rotavirus strains of bovine, simian and porcine origin","volume":"1","author":"Castrucci","year":"1985","journal-title":"Eur J Epidemiol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1297-9716-44-88","article-title":"Different virulence of porcine and porcine-like bovine rotavirus strains with genetically nearly identical genomes in piglets and calves","volume":"44","author":"Park","year":"2013","journal-title":"Vet Res"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e1009237","DOI":"10.1371\/journal.ppat.1009237","article-title":"Infection of porcine small intestinal enteroids with human and pig rotavirus a strains reveals contrasting roles for histo-blood group antigens and terminal sialic acids","volume":"17","author":"Guo","year":"2021","journal-title":"PLoS Pathog"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1017\/erm.2014.2","article-title":"Histo-blood group antigens: a common niche for norovirus and rotavirus","volume":"16","author":"Tan","year":"2014","journal-title":"Expert Rev Mol Med"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/s0264-410x(02)00617-5","article-title":"Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants","volume":"21","author":"Johansen","year":"2003","journal-title":"Vaccine"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.addr.2015.03.007","article-title":"Delivery strategies to enhance oral vaccination against enteric infections","volume":"91","author":"Davitt","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/vaccines11050927","article-title":"Combined live oral priming and intramuscular boosting regimen with Rotarix\u00ae and a nanoparticle-based trivalent rotavirus vaccine evaluated in Gnotobiotic pig models of G4P(6) and G1P(8) human rotavirus infection","volume":"11","author":"Hensley","year":"2023","journal-title":"Vaccine"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"e0021224","DOI":"10.1128\/jvi.00212-24","article-title":"Recombinant bivalent subunit vaccine combining truncated VP4 from P[7] and P(23) induces protective immunity against prevalent porcine rotaviruses","volume":"98","author":"Tang","year":"2024","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1177\/0885328209353642","article-title":"Improved immunogenicity of biodegradable polymer particles entrapped rotavirus vaccine","volume":"25","author":"Nayak","year":"2011","journal-title":"J Biomater Appl"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13567-025-01695-6","article-title":"Intestinal mucosal immune responses induced by oral administration of chitosan nanoparticles encapsulating the PEDV S1 protein","volume":"57","author":"Su","year":"2025","journal-title":"Vet Res"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/02652040802211709","article-title":"Formulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccination","volume":"26","author":"Nayak","year":"2009","journal-title":"J Microencapsul"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1016\/j.vaccine.2005.03.009","article-title":"Mucosal and systemic antibody responses and protection induced by a prime\/boost rotavirus-DNA vaccine in a gnotobiotic pig model","volume":"23","author":"Yuan","year":"2005","journal-title":"Vaccine"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/vaccines8020229","article-title":"A nanoparticle-poly(I:C) combination adjuvant enhances the breadth of the immune response to inactivated influenza virus vaccine in pigs","volume":"8","author":"Renu","year":"2020","journal-title":"Vaccine"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.3390\/v14112522","article-title":"Genetic diversity of porcine Group A rotavirus strains from pigs in South Korea","volume":"14","author":"Park","year":"2022","journal-title":"Viruses"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.virol.2017.03.008","article-title":"Genotypic and epitope characteristics of Group A porcine rotavirus strains circulating in Canada","volume":"507","author":"Naseer","year":"2017","journal-title":"Virology"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3389\/fgene.2020.00828","article-title":"Leveraging a validated in silico approach to elucidate genotype-specific VP7 epitopes and antigenic relationships of porcine rotavirus a","volume":"11","author":"Shepherd","year":"2020","journal-title":"Front Genet"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"110893","DOI":"10.1016\/j.vetmic.2026.110893","article-title":"Assessment of genetic diversity and pathogenicity of porcine rotavirus a, and immunogenicity of a bivalent inactivated vaccine in southern China","volume":"314","author":"Hu","year":"2026","journal-title":"Vet Microbiol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1016\/j.vaccine.2005.02.024","article-title":"Porcine rotavirus strain Gottfried-based human rotavirus candidate vaccines: construction and characterization","volume":"23","author":"Hoshino","year":"2005","journal-title":"Vaccine"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virs.2024.12.001","article-title":"Insights into recent advancements in human and animal rotavirus vaccines: exploring new frontiers","volume":"40","author":"Ghonaim","year":"2025","journal-title":"Virol Sin"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.vetmic.2016.11.029","article-title":"Vaccines for porcine epidemic diarrhea virus and other swine coronaviruses","volume":"206","author":"Gerdts","year":"2017","journal-title":"Vet Microbiol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00970.x","article-title":"Immunology of gut mucosal vaccines","volume":"239","author":"Pasetti","year":"2011","journal-title":"Immunol Rev"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/s0065-3527(08)60329-2","article-title":"Rotaviruses: immunological determinants of protection against infection and disease","volume":"44","author":"Offit","year":"1994","journal-title":"Adv Virus Res"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.vetmic.2016.08.014","article-title":"Unusual outbreak of post-weaning porcine diarrhea caused by single and mixed infections of rotavirus groups a, B, C, and H","volume":"193","author":"Molinari","year":"2016","journal-title":"Vet Microbiol"},{"key":"ref72","first-page":"477","article-title":"Stimulovanie tvorby s\u00e9rov\u00fdch protil\u00e1tok u prasiat vyvolan\u00e9 or\u00e1lnym, podkozn\u00fdm a kombinovan\u00fdm podan\u00edm ziv\u00e9ho alebo i. m. inokulovan\u00edm inaktivovan\u00e9ho porc\u00ednneho rotav\u00edrusu vo olejovom adjuvans (Stimulation of serum antibody formation in pigs by oral, subcutaneous or combined administration of live porcine rotaviruses or intramuscular inoculation of inactivated porcine rotaviruses in an oil adjuvant)","volume":"36","author":"Zuffa","year":"1991","journal-title":"Veterin Med"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/vetsci12020180","article-title":"Isolation, genomic characterization, and immunogenicity evaluation of a G9P(23) porcine rotavirus strain","volume":"12","author":"Wang","year":"2025","journal-title":"Vet Sci"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1586\/erv.12.38","article-title":"Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges","volume":"11","author":"Delrue","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"36198","DOI":"10.1074\/jbc.M111.279232","article-title":"Reactions of beta-propiolactone with nucleobase analogues, nucleosides, and peptides: implications for the inactivation of viruses","volume":"286","author":"Uittenbogaard","year":"2011","journal-title":"J Biol Chem"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1016\/j.vaccine.2012.11.027","article-title":"Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch","volume":"31","author":"Moon","year":"2013","journal-title":"Vaccine"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"6754","DOI":"10.1016\/j.vaccine.2008.10.008","article-title":"Inactivated rotavirus vaccines: a priority for accelerated vaccine development","volume":"26","author":"Jiang","year":"2008","journal-title":"Vaccine"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.3390\/vaccines11121866","article-title":"Role of pre-farrow natural planned exposure of gilts in shaping the passive antibody response to rotavirus a in piglets","volume":"11","author":"Kumar","year":"2023","journal-title":"Vaccine"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41541-019-0132-6","article-title":"The how's and what's of vaccine reactogenicity","volume":"4","author":"Herv\u00e9","year":"2019","journal-title":"NPJ Vaccines"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1086\/424666","article-title":"Safety and immunogenicity of an inactivated hepatitis a vaccine among HIV-infected subjects","volume":"39","author":"Wallace","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza a (H5N1) vaccine","volume":"354","author":"Treanor","year":"2006","journal-title":"N Engl J Med"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S1473-3099(20)30001-3","article-title":"Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial","volume":"20","author":"Groome","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"4368881","DOI":"10.1155\/tbed\/4368881","article-title":"Natural products as potential resource library for control of major swine enteric viruses","volume":"2026","author":"Zhang","year":"2026","journal-title":"Transbound Emerg Dis"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/infdis\/159.1.79","article-title":"Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus","volume":"159","author":"Ward","year":"1989","journal-title":"J Infect Dis"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"690438","DOI":"10.1155\/2010\/690438","article-title":"Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant","volume":"2010","author":"Jin","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"108162","DOI":"10.1016\/j.intimp.2021.108162","article-title":"A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines","volume":"100","author":"Ghasemiyeh","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1740572","DOI":"10.3389\/fmicb.2025.1740572","article-title":"TLR agonists as adjuvants for viral vaccines: mechanisms, applications, and future directions","volume":"16","author":"Shao","year":"2026","journal-title":"Front Microbiol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1016\/j.vaccine.2015.07.011","article-title":"Immunogenicity of porcine P(6), P[7]-specific \u25b3VP8* rotavirus subunit vaccines with a tetanus toxoid universal T cell epitope","volume":"33","author":"Wen","year":"2015","journal-title":"Vaccine"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1080\/21645515.2019.1710412","article-title":"Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine","volume":"16","author":"Lakatos","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"149919","DOI":"10.1016\/j.bbrc.2024.149919","article-title":"Adjuvant-free parenterally injectable vaccine platform that harnesses previously induced IgG as an antigen delivery carrier","volume":"711","author":"Kawai","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"110241","DOI":"10.1016\/j.vetmic.2024.110241","article-title":"Virus-like particles vaccine based on co-expression of G5 porcine rotavirus VP2-VP6-VP7 induces a powerful immune protective response in mice","volume":"298","author":"Yan","year":"2024","journal-title":"Vet Microbiol"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1128\/JVI.01727-07","article-title":"Differential requirements for T cells in viruslike particle- and rotavirus-induced protective immunity","volume":"82","author":"Blutt","year":"2008","journal-title":"J Virol"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1080\/21645515.2015.1054583","article-title":"Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic","volume":"11","author":"Wen","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"e70031","DOI":"10.1002\/cbf.70031","article-title":"Biotechnological interventions for the production of subunit vaccines against Group A rotavirus","volume":"42","author":"Prajapati","year":"2024","journal-title":"Cell Biochem Funct"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.vetmic.2017.12.014","article-title":"Epidemiological analysis of porcine rotavirus a genotypes in Germany","volume":"214","author":"Wenske","year":"2018","journal-title":"Vet Microbiol"},{"key":"ref98","volume-title":"PROSYSTEM\u00ae RCE: Porcine Rotavirus Vaccine Modified-live Virus","year":"2025"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1297-9716-42-112","article-title":"Genetic diversity of Group A rotaviruses associated with repeated outbreaks of diarrhea in a farrow-to-finish farm: identification of a porcine rotavirus strain bearing a novel VP7 genotype, G26","volume":"42","author":"Miyazaki","year":"2011","journal-title":"Vet Res"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1099\/vir.0.068403-0","article-title":"Novel porcine-like human G26P(19) rotavirus identified in hospitalized paediatric diarrhoea patients in Ho Chi Minh City, Vietnam","volume":"95","author":"My","year":"2014","journal-title":"J Gen Virol"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.rdc.2013.02.013","article-title":"Localized cutaneous fibrosing disorders","volume":"39","author":"Yaqub","year":"2013","journal-title":"Rheum Dis Clin N Am"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/ani12030251","article-title":"Occurrence of rotavirus a genotypes and other enteric pathogens in diarrheic suckling piglets from Spanish swine farms","volume":"12","author":"Monteagudo","year":"2022","journal-title":"Animals"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0378-1135(90)90105-5","article-title":"Evaluation of killed and modified live porcine rotavirus vaccines in cesarean derived colostrum deprived pigs","volume":"22","author":"Welter","year":"1990","journal-title":"Vet Microbiol"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.2460\/ajvr.1986.47.08.1697","article-title":"Efficacy of an orally administered modified-live porcine-origin rotavirus vaccine against postweaning diarrhea in pigs","volume":"47","author":"Hoblet","year":"1986","journal-title":"Am J Vet Res"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S1473-3099(14)70832-1","article-title":"Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis","volume":"14","author":"Leshem","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1128\/JCM.05590-11","article-title":"Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq","volume":"50","author":"Zeller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"7795","DOI":"10.1128\/JVI.78.14.7795-7802.2004","article-title":"Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3","volume":"78","author":"Hoshino","year":"2004","journal-title":"J Virol"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"116346","DOI":"10.1016\/j.diagmicrobio.2024.116346","article-title":"Antigenic epitope analysis of Pakistani G3 and G9 rotavirus strains compared to vaccine strains revealed multiple amino acid differences","volume":"109","author":"Sadiq","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"e33887","DOI":"10.1016\/j.heliyon.2024.e33887","article-title":"Comparative analysis of the RVA VP7 and VP4 antigenic epitopes circulating in Iran and the Rotarix and RotaTeq vaccines","volume":"10","author":"Fallah","year":"2024","journal-title":"Heliyon"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s40265-024-02083-8","article-title":"Influenza vaccine effectiveness and Progress towards a universal influenza vaccine","volume":"84","author":"Cowling","year":"2024","journal-title":"Drugs"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"12578","DOI":"10.1073\/pnas.1712377114","article-title":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains","volume":"114","author":"Zost","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/infdis\/174.2.276","article-title":"Role of maternally derived circulating antibodies in protection of neonatal swine against porcine Group A rotavirus","volume":"174","author":"Ward","year":"1996","journal-title":"J Infect Dis"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1128\/JVI.73.1.186-197.1999","article-title":"Effects of maternal antibodies on protection and development of antibody responses to human rotavirus in gnotobiotic pigs","volume":"73","author":"Hodgins","year":"1999","journal-title":"J Virol"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"e1009010","DOI":"10.1371\/journal.ppat.1009010","article-title":"Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries","volume":"16","author":"Otero","year":"2020","journal-title":"PLoS Pathog"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.3390\/v14112354","article-title":"Rotavirus a inoculation and Oral vitamin a supplementation of vitamin a deficient pregnant sows enhances maternal adaptive immunity and passive protection of piglets against virulent rotavirus a","volume":"14","author":"Chepngeno","year":"2022","journal-title":"Viruses"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.livsci.2017.08.011","article-title":"Immune response of mature cows subjected to annual booster vaccination against neonatal calf diarrhoea with two different commercial vaccines: a non-inferiority study","volume":"204","author":"Durel","year":"2017","journal-title":"Livest Sci"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.chom.2020.07.001","article-title":"Antibody feedback limits the expansion of B cell responses to malaria vaccination but drives diversification of the humoral response","volume":"28","author":"McNamara","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1172\/JCI14397","article-title":"Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb","volume":"109","author":"Feng","year":"2002","journal-title":"J Clin Invest"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nri3907","article-title":"Living in harmony","volume":"15","author":"Bird","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jviromet.2015.07.016","article-title":"Isolation and propagation of the animal rotaviruses in MA-104 cells\u201430 years of practical experience","volume":"223","author":"Otto","year":"2015","journal-title":"J Virol Methods"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.vaccine.2021.03.033","article-title":"Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine","volume":"39","author":"Hamidi","year":"2021","journal-title":"Vaccine"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"117","DOI":"10.7774\/cevr.2016.5.2.117","article-title":"Influenza virus vaccine for neglected hosts: horses and dogs","volume":"5","author":"Na","year":"2016","journal-title":"Clin Exp Vaccine Res"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3390\/v16081198","article-title":"Generation of recombinant authentic live attenuated human rotavirus vaccine strain RIX4414 (Rotarix\u00ae) from cloned cDNAs using reverse genetics","volume":"16","author":"Fukuda","year":"2024","journal-title":"Viruses"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1586\/14760584.7.10.1475","article-title":"RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine","volume":"7","author":"Chandran","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12934-021-01583-6","article-title":"Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus","volume":"20","author":"Dalvie","year":"2021","journal-title":"Microb Cell Factories"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0065-3527(06)68006-8","article-title":"Vaccines for viral and parasitic diseases produced with baculovirus vectors","volume":"68","author":"van Oers","year":"2006","journal-title":"Adv Virus Res"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.3390\/v14102250","article-title":"Antibody response to rotavirus C pre-farrow natural planned exposure to gilts and their piglets","volume":"14","author":"Kumar","year":"2022","journal-title":"Viruses"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/v16060978","article-title":"Human rotaviruses of multiple genotypes acquire conserved VP4 mutations during serial passage","volume":"16","author":"Carter","year":"2024","journal-title":"Viruses"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/v12040408","article-title":"Amino acid substitutions in positions 385 and 393 of the hydrophobic region of VP4 may be associated with rotavirus attenuation and cell culture adaptation","volume":"12","author":"Guo","year":"2020","journal-title":"Viruses"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1128\/JVI.72.1.330-338.1998","article-title":"Antibody-secreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human rotavirus","volume":"72","author":"Yuan","year":"1998","journal-title":"J Virol"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1099\/00222615-43-6-397","article-title":"Human immunity to rotavirus","volume":"43","author":"Molyneaux","year":"1995","journal-title":"J Med Microbiol"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3390\/vaccines10091529","article-title":"Probiotic as adjuvant significantly improves protection of the Lanzhou trivalent rotavirus vaccine against heterologous challenge in a Gnotobiotic pig model of human rotavirus infection and disease","volume":"10","author":"Parreno","year":"2022","journal-title":"Vaccine"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/s0264-410x(98)00317-x","article-title":"Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles","volume":"17","author":"Jiang","year":"1999","journal-title":"Vaccine"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3390\/vaccines10071120","article-title":"Advances in infectious disease vaccine adjuvants","volume":"10","author":"Fan","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.1016\/j.vaccine.2020.08.054","article-title":"Adjuvants for swine vaccines: mechanisms of actions and adjuvant effects","volume":"38","author":"Charerntantanakul","year":"2020","journal-title":"Vaccine"},{"key":"ref136","volume-title":"Merck Veterinary Manual","author":"Tizard","year":"2023"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3390\/vaccines8030554","article-title":"Inflammasome-mediated immunogenicity of clinical and experimental vaccine adjuvants","volume":"8","author":"Reinke","year":"2020","journal-title":"Vaccine"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front Immunol"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"990900","DOI":"10.3389\/fimmu.2022.990900","article-title":"Mechanism of activation of porcine dendritic cells by an \u03b1-D-glucan nanoparticle adjuvant and a nanoparticle\/poly(I:C) combination adjuvant","volume":"13","author":"Hernandez-Franco","year":"2022","journal-title":"Front Immunol"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.3389\/fimmu.2018.02874","article-title":"Adjuvants enhancing cross-presentation by dendritic cells: the key to more effective vaccines?","volume":"9","author":"Ho","year":"2018","journal-title":"Front Immunol"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1016\/j.vaccine.2004.01.061","article-title":"Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type","volume":"22","author":"Rimaniol","year":"2004","journal-title":"Vaccine"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"E1122","DOI":"10.1073\/pnas.1300392110","article-title":"Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells","volume":"110","author":"McKee","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/s0264-410x(02)00169-x","article-title":"Mechanisms of stimulation of the immune response by aluminum adjuvants","volume":"20","author":"HogenEsch","year":"2002","journal-title":"Vaccine"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"579761","DOI":"10.3389\/fimmu.2020.579761","article-title":"Vaccine adjuvants differentially affect kinetics of antibody and germinal center responses","volume":"11","author":"Pedersen","year":"2020","journal-title":"Front Immunol"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/978-1-4615-1823-5_10","article-title":"MF59. Design and evaluation of a safe and potent adjuvant for human vaccines","volume":"6","author":"Ott","year":"1995","journal-title":"Pharm Biotechnol"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.cell.2006.02.019","article-title":"Translating innate immunity into immunological memory: implications for vaccine development","volume":"124","author":"Pulendran","year":"2006","journal-title":"Cell"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1016\/j.vaccine.2005.10.027","article-title":"Analysis of costimulatory molecule expression on antigen-specific T and B cells during the induction of adjuvant-induced Th1 and Th2 type responses","volume":"24","author":"Smith","year":"2006","journal-title":"Vaccine"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.rvsc.2017.03.007","article-title":"Oil-based adjuvants delivered intradermally induce high primary IgG2 immune response in swine","volume":"114","author":"Oreskovic","year":"2017","journal-title":"Res Vet Sci"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fimmu.2012.00406","article-title":"Mechanism of immunopotentiation and safety of aluminum adjuvants","volume":"3","author":"Hogenesch","year":"2013","journal-title":"Front Immunol"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"1439418","DOI":"10.3389\/fimmu.2024.1439418","article-title":"The adjuvant BcfA activates antigen presenting cells through TLR4 and supports TFH and TH1 while attenuating TH2 gene programming","volume":"15","author":"Shamseldin","year":"2024","journal-title":"Front Immunol"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4049\/jimmunol.181.1.17","article-title":"Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3","volume":"181","author":"Li","year":"2008","journal-title":"J Immunol"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.4049\/jimmunol.181.6.3755","article-title":"Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome","volume":"181","author":"Kool","year":"2008","journal-title":"J Immunol"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.tips.2009.03.005","article-title":"Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants","volume":"30","author":"Aimanianda","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1016\/j.vaccine.2004.03.032","article-title":"Aluminium adjuvants--in retrospect and prospect","volume":"22","author":"Lindblad","year":"2004","journal-title":"Vaccine"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.1039\/d3tb02861e","article-title":"Vaccine adjuvants: current status, research and development, licensing, and future opportunities","volume":"12","author":"Cui","year":"2024","journal-title":"J Mater Chem B"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3390\/vaccines11081391","article-title":"Advances in adjuvanted influenza vaccines","volume":"11","author":"Shichinohe","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1016\/j.vaccine.2019.07.098","article-title":"Adjuvant systems for vaccines: 13 years of post-licensure experience in diverse populations have progressed the way adjuvanted vaccine safety is investigated and understood","volume":"37","author":"Laup\u00e8ze","year":"2019","journal-title":"Vaccine"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"1428713","DOI":"10.3389\/fvets.2024.1428713","article-title":"Safety and efficacy of toll-like receptor agonists as therapeutic agents and vaccine adjuvants for infectious diseases in animals: a systematic review","volume":"11","author":"Oboge","year":"2024","journal-title":"Front Vet Sci"},{"key":"ref160","volume-title":"Adjuvants and Vaccines","year":"2024"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.vaccine.2004.07.050","article-title":"Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro","volume":"23","author":"Morefield","year":"2005","journal-title":"Vaccine"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/14760584.2023.2238807","article-title":"In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives","volume":"22","author":"Zeng","year":"2023","journal-title":"Expert Rev Vaccines"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1292\/jvms.59.421","article-title":"A field trial of oil adjuvanten trivalent Actinobacillus pleuropneumoniae vaccine","volume":"59","author":"Oishi","year":"1997","journal-title":"J Vet Med Sci"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"1336239","DOI":"10.3389\/fimmu.2024.1336239","article-title":"A novel CpG ODN compound adjuvant enhances immune response to spike subunit vaccines of porcine epidemic diarrhea virus","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/vaccines9030222","article-title":"Natural and synthetic Saponins as vaccine adjuvants","volume":"9","author":"Wang","year":"2021","journal-title":"Vaccine"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.4172\/2329-6836.1000e113","article-title":"QS-21: a potent vaccine adjuvant","volume":"3","author":"Zhu","year":"2016","journal-title":"Nat Prod Chem Res"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"1813847","DOI":"10.3389\/fimmu.2026.1813847","article-title":"The challenge of one billion adjuvanted vaccine doses: evaluating scalability, sustainability, and supply capacity of Quillaja saponin QS-21 for large-scale vaccine demand","volume":"17","author":"Padilla","year":"2026","journal-title":"Front Immunol"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1016\/s0264-410x(03)00267-6","article-title":"Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2\/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigs","volume":"21","author":"Nguyen","year":"2003","journal-title":"Vaccine"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.vetimm.2013.07.007","article-title":"Early inflammatory response to the saponin adjuvant matrix-M in the pig","volume":"158","author":"Fossum","year":"2014","journal-title":"Vet Immunol Immunopathol"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.vaccine.2014.11.034","article-title":"Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs","volume":"33","author":"Thomas","year":"2015","journal-title":"Vaccine"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0165-2478(90)90128-d","article-title":"The iscom: an immunostimulating system","volume":"25","author":"Morein","year":"1990","journal-title":"Immunol Lett"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/344873a0","article-title":"Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs","volume":"344","author":"Takahashi","year":"1990","journal-title":"Nature"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/icb.2011.71","article-title":"ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway","volume":"90","author":"Wilson","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"ref174","first-page":"107","article-title":"Etude de l'effet adjuvant du Quil-A sur la r\u00e9ponse immunitaire humorale chez le porc (Adjuvant effect of Quil-A on the porcine humoral immune response (author's transl))","volume":"129","author":"Houdayer","year":"1978","journal-title":"Ann Immunol"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/0264-410x(93)90039-z","article-title":"Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems","volume":"11","author":"Holmgren","year":"1993","journal-title":"Vaccine"},{"key":"ref176","first-page":"42","article-title":"Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant","volume":"50","author":"Holmgren","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"ref177","first-page":"301","article-title":"Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens","volume":"59","author":"Lycke","year":"1986","journal-title":"Immunology"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1586\/14760584.6.5.821","article-title":"Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins","volume":"6","author":"Connell","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.micpath.2015.08.013","article-title":"B subunits of cholera toxin and thermolabile enterotoxin of Escherichia coli have similar adjuvant effect as whole molecules on rotavirus 2\/6-VLP specific antibody responses and induce a Th17-like response after intrarectal immunization","volume":"89","author":"Thiam","year":"2015","journal-title":"Microb Pathog"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1016\/j.vaccine.2009.03.043","article-title":"Comparison of the efficacy of rotavirus VLP vaccines to a live homologous rotavirus vaccine in a pig model of rotavirus disease","volume":"27","author":"El-Attar","year":"2009","journal-title":"Vaccine"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3389\/fimmu.2016.00563","article-title":"Intestinal innate antiviral immunity and Immunobiotics: beneficial effects against rotavirus infection","volume":"7","author":"Villena","year":"2016","journal-title":"Front Immunol"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1016\/j.vaccine.2015.05.026","article-title":"Rotavirus VP6 preparations as a non-replicating vaccine candidates","volume":"33","author":"Jalilvand","year":"2015","journal-title":"Vaccine"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.colsurfb.2009.08.022","article-title":"Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations","volume":"75","author":"Anderson","year":"2010","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"3763","DOI":"10.1128\/IAI.00217-10","article-title":"Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA with adjuvant monophosphoryl lipid a protects swine from a homologous but not a heterologous challenge","volume":"78","author":"Fusco","year":"2010","journal-title":"Infect Immun"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3389\/fimmu.2018.00934","article-title":"Mucosal immunity and protective efficacy of intranasal inactivated influenza vaccine is improved by chitosan nanoparticle delivery in pigs","volume":"9","author":"Dhakal","year":"2018","journal-title":"Front Immunol"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"558349","DOI":"10.3389\/fbioe.2020.558349","article-title":"Chitosan nanoparticle based mucosal vaccines delivered against infectious diseases of poultry and pigs","volume":"8","author":"Renu","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"8843","DOI":"10.1128\/jvi.74.19.8843-8853.2000","article-title":"Intranasal administration of 2\/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs","volume":"74","author":"Yuan","year":"2000","journal-title":"J Virol"},{"key":"ref188","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s42770-018-0022-5","article-title":"Evaluation on the efficacy and immunogenicity of recombinant DNA plasmids expressing S gene from porcine epidemic diarrhea virus and VP7 gene from porcine rotavirus","volume":"50","author":"Yin","year":"2019","journal-title":"Brazilian J Microbiol"},{"key":"ref189","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.3390\/vaccines11121788","article-title":"Co-formulation of recombinant porcine IL-18 enhances the onset of immune response in a new Lawsonia intracellularis vaccine","volume":"11","author":"Hidalgo-Gajardo","year":"2023","journal-title":"Vaccine"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.cyto.2017.04.013","article-title":"Cytokines in the management of rotavirus infection: a systematic review of in vivo studies","volume":"96","author":"Gandhi","year":"2017","journal-title":"Cytokine"},{"key":"ref191","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J Immunol"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/jbm.b.34215","article-title":"Surface assembly of poly(I:C) on polyethyleneimine-modified gelatin nanoparticles as immunostimulatory carriers for mucosal antigen delivery","volume":"107","author":"Lin","year":"2019","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.virol.2007.01.041","article-title":"Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB\/c mice","volume":"363","author":"McNeal","year":"2007","journal-title":"Virology"},{"key":"ref194","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0042-6822(91)90888-i","article-title":"The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin","volume":"181","author":"Fiore","year":"1991","journal-title":"Virology"},{"key":"ref195","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/vim.2005.18.27","article-title":"Rotavirus NSP4: a multifunctional viral enterotoxin","volume":"18","author":"Ball","year":"2005","journal-title":"Viral Immunol"},{"key":"ref196","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1128\/JVI.72.5.3666-3672.1998","article-title":"Mutations in rotavirus nonstructural glycoprotein NSP4 are associated with altered virus virulence","volume":"72","author":"Zhang","year":"1998","journal-title":"J Virol"},{"key":"ref197","doi-asserted-by":"publisher","first-page":"11574","DOI":"10.1128\/jvi.74.24.11574-11580.2000","article-title":"Functional mapping of protective domains and epitopes in the rotavirus VP6 protein","volume":"74","author":"Choi","year":"2000","journal-title":"J Virol"},{"key":"ref198","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1743-422X-8-3","article-title":"Prime immunization with rotavirus VLP 2\/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice","volume":"8","author":"Zhou","year":"2011","journal-title":"Virol J"},{"key":"ref199","doi-asserted-by":"publisher","first-page":"623072","DOI":"10.3389\/fimmu.2020.623072","article-title":"Total recall: intestinal TRM cells in health and disease","volume":"11","author":"Paap","year":"2021","journal-title":"Front Immunol"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev-animal-020518-115014","article-title":"Importance of the major histocompatibility complex (swine leukocyte antigen) in swine health and biomedical research","volume":"8","author":"Hammer","year":"2020","journal-title":"Annu Rev Anim Biosci"},{"key":"ref201","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.vetmic.2006.07.014","article-title":"Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus","volume":"118","author":"Wesley","year":"2006","journal-title":"Vet Microbiol"},{"key":"ref202","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12985-024-02440-9","article-title":"Design of multi-epitope vaccine against porcine rotavirus using computational biology and molecular dynamics simulation approaches","volume":"21","author":"Zhu","year":"2024","journal-title":"Virol J"},{"key":"ref203","doi-asserted-by":"publisher","first-page":"106941","DOI":"10.1016\/j.compbiomed.2023.106941","article-title":"Immunoinformatics-guided design of a multi-valent vaccine against rotavirus and norovirus (ChRNV22)","volume":"159","author":"de Oliveira Matos","year":"2023","journal-title":"Comput Biol Med"},{"key":"ref204","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1080\/07391102.2023.2226721","article-title":"T cell epitope based vaccine design while targeting outer capsid proteins of rotavirus strains infecting neonates: an immunoinformatics approach","volume":"42","author":"Sharma","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"ref205","doi-asserted-by":"publisher","first-page":"112079","DOI":"10.1016\/j.intimp.2024.112079","article-title":"Lactiplantibacillus plantarum surface-displayed VP6 (PoRV) protein can prevent PoRV infection in piglets","volume":"133","author":"Wang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"ref206","doi-asserted-by":"publisher","first-page":"6753","DOI":"10.1128\/JVI.00601-08","article-title":"Generation of recombinant rotavirus with an antigenic mosaic of cross-reactive neutralization epitopes on VP4","volume":"82","author":"Komoto","year":"2008","journal-title":"J Virol"},{"key":"ref207","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/BF01322686","article-title":"Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus","volume":"140","author":"Dunn","year":"1995","journal-title":"Arch Virol"},{"key":"ref208","doi-asserted-by":"publisher","first-page":"eaam5434","DOI":"10.1126\/scitranslmed.aam5434","article-title":"VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans","volume":"9","author":"Nair","year":"2017","journal-title":"Sci Transl Med"},{"key":"ref209","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.vetimm.2014.08.006","article-title":"A single, low dose oral antigen exposure in newborn piglets primes mucosal immunity if administered with CpG oligodeoxynucleotides and polyphosphazene adjuvants","volume":"161","author":"Pasternak","year":"2014","journal-title":"Vet Immunol Immunopathol"},{"key":"ref210","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/vaccines6030064","article-title":"A universal influenza virus vaccine candidate tested in a pig vaccination-infection model in the presence of maternal antibodies","volume":"6","author":"Sunwoo","year":"2018","journal-title":"Vaccine"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1896748\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:22:19Z","timestamp":1784308939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1896748\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":210,"alternative-id":["10.3389\/fvets.2026.1896748"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2026.1896748","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"article-number":"1896748"}}